|
English
|
正體中文
|
简体中文
|
总笔数 :0
|
|
造访人次 :
51994162
在线人数 :
761
教育部委托研究计画 计画执行:国立台湾大学图书馆
|
|
|
显示项目 301041-301050 / 2348439 (共234844页)
<< < 30100 30101 30102 30103 30104 30105 30106 30107 30108 30109 > >>
每页显示[10|25|50]项目
| 中國醫藥大學 |
2007.09 |
Cytogenetic variability in the proportion of abnormal cells between the various tissues in prenatally detected mosaic tetrasomy 12p
|
陳持平(Chen CP)*; 蔡輔仁(Fuu-Jen Tsai); (Chern SR); (Lee CC); (Town DD); (Wang W) |
| 中國醫藥大學 |
2007.09 |
Cytogenetic variability in the proportion of abnormal cells between the various tissues in prenatally detected mosaic tetrasomy 12p
|
陳持平(Chen CP)*; 蔡輔仁(Fuu-Jen Tsai); (Chern SR); (Lee CC); (Town DD); (Wang W) |
| 臺大學術典藏 |
2020-09-29T16:47:19Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang, YW; Tsai, CH; Lin, CC; Tien, FM; Chen, YW; HSIN-YI LIN; Yao, M; Lin, YC; Lin, CT; Cheng, CL; Tang, JL; Chou, WC; Hou, HA; Tien, HF |
| 臺大學術典藏 |
2020-10-28T08:35:05Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang Y.-W.; CHENG-HONG TSAI; Lin C.-C.; Tien F.-M.; Chen Y.-W.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; Hou H.-A.; Tien H.-F.; Yao M.; Lin H.-Y. |
| 臺大學術典藏 |
2021-01-04T12:12:16Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Lin C.-C.; Wang Y.-W.; Tsai C.-H.; Tien F.-M.; Chen Y.-W.; Lin H.-Y.; Yao M.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; Hou H.-A.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2020 |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Hou H.-A.; Chou W.-C.; Tang J.-L.; Cheng C.-L.; Lin C.-T.; Lin Y.-C.; MING YAO; Lin H.-Y.; Chen Y.-W.; Tien F.-M.; Lin C.-C.; Tsai C.-H.; Wang Y.-W.; Tien H.-F. |
| 臺大學術典藏 |
2021-07-21T03:42:30Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang Y.-W.; Tsai C.-H.; Lin C.-C.; Tien F.-M.; Chen Y.-W.; Lin H.-Y.; Yao M.; LIN YUN-CHU; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; Hou H.-A.; Tien H.-F. |
| 臺大學術典藏 |
2021-07-21T07:23:24Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang Y.-W.; Tsai C.-H.; Lin C.-C.; TIEN FENG-MING; Chen Y.-W.; Lin H.-Y.; Yao M.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; Hou H.-A.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:12Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang Y.-W.; Tsai C.-H.; Lin C.-C.; Tien F.-M.; Chen Y.-W.; Lin H.-Y.; Yao M.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; HSIN-AN HOU; Tien H.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:11Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang Y.-W.;Tsai C.-H.;Lin C.-C.;Tien F.-M.;Chen Y.-W.;Lin H.-Y.;Yao M.;Lin Y.-C.;Lin C.-T.;Cheng C.-L.;Tang J.-L.;Wen-Chien Chou;Hou H.-A.;Tien H.-F.; Wang Y.-W.; Tsai C.-H.; Lin C.-C.; Tien F.-M.; Chen Y.-W.; Lin H.-Y.; Yao M.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; Tang J.-L.; WEN-CHIEN CHOU; Hou H.-A.; Tien H.-F. |
显示项目 301041-301050 / 2348439 (共234844页)
<< < 30100 30101 30102 30103 30104 30105 30106 30107 30108 30109 > >>
每页显示[10|25|50]项目
|
